- Home
- VANI vs RANI Comparison
VANI vs RANI Comparison
Compare VANI & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- RANI
- Stock Information
- Founded
- VANI 1998
- RANI 2012
- Country
- VANI United States
- RANI United States
- Employees
- VANI N/A
- RANI N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RANI Medicinal Chemicals and Botanical Products
- Sector
- VANI Health Care
- RANI Health Care
- Exchange
- VANI Nasdaq
- RANI Nasdaq
- Market Cap
- VANI 65.2M
- RANI 55.3M
- IPO Year
- VANI 2014
- RANI 2021
- Fundamental
- Price
- VANI $1.02
- RANI $1.23
- Analyst Decision
- VANI Strong Buy
- RANI Strong Buy
- Analyst Count
- VANI 1
- RANI 6
- Target Price
- VANI $4.00
- RANI $11.33
- AVG Volume (30 Days)
- VANI 107.5K
- RANI 145.5K
- Earning Date
- VANI 05-12-2025
- RANI 03-31-2025
- Dividend Yield
- VANI N/A
- RANI N/A
- EPS Growth
- VANI N/A
- RANI N/A
- EPS
- VANI N/A
- RANI N/A
- Revenue
- VANI N/A
- RANI N/A
- Revenue This Year
- VANI N/A
- RANI N/A
- Revenue Next Year
- VANI N/A
- RANI N/A
- P/E Ratio
- VANI N/A
- RANI N/A
- Revenue Growth
- VANI N/A
- RANI N/A
- 52 Week Low
- VANI $1.00
- RANI $1.20
- 52 Week High
- VANI $2.22
- RANI $8.75
- Technical
- Relative Strength Index (RSI)
- VANI 34.58
- RANI 33.72
- Support Level
- VANI $1.06
- RANI $1.30
- Resistance Level
- VANI $1.16
- RANI $1.56
- Average True Range (ATR)
- VANI 0.04
- RANI 0.09
- MACD
- VANI -0.00
- RANI -0.03
- Stochastic Oscillator
- VANI 12.50
- RANI 8.33
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.